Royalty Pharma
RPRX
#1031
Rank
S$29.71 B
Marketcap
S$50.95
Share price
-0.43%
Change (1 day)
23.55%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: S$29.71 Billion

As of January 2026 Royalty Pharma has a market cap of S$29.71 Billion. This makes Royalty Pharma the world's 1031th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026S$29.71 B1.19%
2025S$29.36 B43.57%
2024S$20.45 B-8.05%
2023S$22.24 B-4.82%
2022S$23.36 B1%
2021S$23.13 B-9.96%
2020S$25.69 B

End of Day market cap according to different sources

On Jan 17th, 2026 the market cap of Royalty Pharma was reported to be:

S$29.41 Billion
by Nasdaq info icon info icon
S$29.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ANI Pharmaceuticals
ANIP
S$2.45 B-91.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$273.01 B 818.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.199 T 3,935.98%๐Ÿ‡บ๐Ÿ‡ธ USA